Background: Pre-eclampsia is one of the causes of maternal morbidity and mortality throughout the world. It is common problem in developing countries. This study was aimed to assess the maternal outcomes of pre-eclampsia management among pregnant women at Gandhi Memorial Hospital. Methods: A retrospective cross-sectional study was conducted on preeclamptic women who were admitted to maternity ward of Gandhi Memorial Hospital in a one year period. Data regarding patient characteristics and treatment outcome (eg. maternal death, maternal complication, hospital stay) were collected. Data was collected using data collection format from patient medical charts. Epinfo version 7 was used for data entry and data was analyzed using SPSS version 21. Descriptive statistics and logistic regression were used. All the statistical tests were significant at P-value < 0.05. Results: A total of 200 mothers’ medical charts were reviewed. One hundred sixty five (82.5%) pregnant women were diagnosed with severe preeclampsia. More than one third (35.5%) of the women developed complications. The most common maternal complication was HELLP syndrome. Mothers with gestational age less than 37 weeks were 5.2 times more likely to develop complication [AOR=5.22, 95% CI = 2.21- 12.3]. Mothers with antipartum preeclampsia were 8.7 times more likely to have prolonged hospital stay [OR=8.7 (95% CI=1.35- 10.02]. Conclusion: The commonly seen poor treatment outcomes in preclamptic mothers were magnesium sulphate toxicity, prolonged hospital stay and development of complications. Preeclampsia at gestational age of less than 37 weeks significantly increases the risk of developing maternal complication.